SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Verizon Master Trust issued approximately $1 billion in asset-backed notes across four classes (A-1a, A-1b, B, and C) on the Closing Date of September 22, 2026, creating direct financial obligations documented by an Indenture and Account Control Agreement. This is a material debt issuance under Item 1.01, creating new financial obligations that would affect a reasonable investor's assessment of the registrant's capital structure and leverage.
View raw filing on EDGAR →IRSA has approved an additional investment of up to USD 4,000,000 in Golden Juniors Segregated Portfolio, an investment fund managed by a company controlled by the Chairman. This is a material capital deployment decision involving a related-party transaction (the fund manager is controlled by Chairman Eduardo Sergio Elsztain) that required Audit Committee approval under Argentine securities law. While the investment is strategic (diversifying liquidity into emerging sectors and precious metals/mining), it does not fit the specific event categories of debt issuance, M&A, or dilutive issuance; it is best classified as an operational/strategic business decision with governance oversight.
View raw filing on EDGAR →This exhibit announces the completion of a business combination between newcleo plc and NewHold Investment Corp III (a SPAC), with newcleo raising $247 million in gross proceeds and beginning trading on Nasdaq under ticker "NWCL" on September 22, 2026. The transaction closed following shareholder approval on September 17, 2026, and valued newcleo at approximately $2.4 billion pre-money equity value. This is a material change-of-control event that directly affects the registrant's capital structure, public listing status, and financial position.
View raw filing on EDGAR →Cable One borrowed $700 million under its existing $1.25 billion revolving credit facility on September 17-18, 2026, to increase cash on hand and preserve financial flexibility.
View raw filing on EDGAR →OpenText announced a conditional notice of redemption of $1.0 billion in 2027 Notes and is exploring a potential offering of senior secured notes pursuant to Rule 144A and Regulation S. While the redemption itself is a refinancing activity, the core material event is the company's exploration of a new debt issuance to fund the redemption. This represents the creation of a new direct financial obligation, which is the hallmark of debt_issuance. The confidence is moderate (0.75) because the offering is still exploratory and subject to financing conditions, but the materiality is clear given the $1 billion scale and strategic importance to the company's capital structure.
View raw filing on EDGAR →Willis Lease Finance Corporation entered into a private placement agreement to issue 1,750,000 shares of Series B Preferred Stock at $20.00 per share for approximately $35 million in gross proceeds. The securities are unregistered and issued in reliance on Section 4(a)(2) of the Securities Act, which is the classic private placement exemption. This is a material capital raise that dilutes existing shareholders and represents a significant financing event for the company.
View raw filing on EDGAR →The filing discloses distributions made to certificateholders (Class B and Class C) on the August 12, 2026 distribution date, with payment revisions and additional payments made on September 14, 2026. Although Item 6.04 is titled "Failure to Make a Required Distribution," the actual disclosure describes successful distributions and additional payments to certificateholders, which constitutes a dividend or distribution event. The materiality is supported by the specific dollar amounts ($794,200.72 principal and $27,756.20 interest) and the involvement of multiple certificateholder classes in a mortgage trust structure.
View raw filing on EDGAR →Benjamin Hart was appointed to Group 1 Automotive's Board of Directors effective November 1, 2026, pursuant to a Stockholder Agreement with Conifer Management, one of the company's largest shareholders. Hart is a member of the investment team for Acacia funds managed by Conifer, and the appointment expands the board from ten to eleven directors.
View raw filing on EDGAR →This exhibit announces that Houdini Swap, SOL Strategies' wholly-owned privacy-focused cross-chain swap aggregator acquired in June 2026, has crossed US$3 billion in cumulative swap volume with US$260 million added since acquisition. While the disclosure highlights a significant operational milestone for a material business line, it is neither a discrete M&A event (the acquisition closed in June), nor a financial result, nor a governance matter. The announcement reflects operational performance and business traction of an acquired asset, making it an operational milestone that would be material to investors assessing the company's business trajectory and the value of its Houdini acquisition.
View raw filing on EDGAR →VersaBank announced the expansion of its Structured Receivable Program (SRP) to the U.S. small business sector, significantly broadening its addressable market. The company estimates this expansion "more than doubles the size of our market opportunity in the U.S." and supports a target of "at least US$3 billion in additional U.S. SRP fundings next year." This is a material strategic and operational milestone—a major product launch and market expansion—that would affect a reasonable investor's assessment of the company's growth prospects and revenue potential, though it does not fit the specific categories of M&A, workforce reduction, or other named operational events.
View raw filing on EDGAR →This news release discloses a material regulatory milestone: British Columbia's Environmental Assessment Office has updated Seabridge on the reconsideration process for the Substantially Started Designation (SSD) of the KSM Project, a principal asset. The disclosure describes the procedural timeline and next steps following a June 2026 court ruling that required the EAO to reconsider the SSD. This is a material operational/regulatory event affecting the company's flagship project development, but does not fit a specific named event type—it is neither a discrete M&A transaction, a workforce action, nor a financial obligation. It is clearly operational in nature and would affect a reasonable investor's assessment of project permitting status.
View raw filing on EDGAR →Canagold closed a $7.1 million private placement consisting of 5.3 million common shares at $0.47 and 8.8 million flow-through shares at $0.52. This is a dilutive equity issuance on a private placement basis. The transaction is material: it raises significant capital, increases share count substantially, and notably increases insider Sun Valley's ownership from 48.25% to 49.75%, triggering MI 61-101 related-party transaction disclosure requirements.
View raw filing on EDGAR →BlackBerry announced the first design win for Alloy Kore with Coretura, adding over $100 million to QNX royalty backlog—described as "the largest design win in QNX history." This is a material commercial milestone for a core business division (QNX), representing a significant strategic partnership and revenue opportunity. While not a traditional M&A transaction, it is a major operational and commercial achievement that would affect a reasonable investor's assessment of the company's growth prospects and market position in the software-defined vehicle space.
View raw filing on EDGAR →The filing's primary disclosure is the appointment of Ravi Srivastava as Chief Financial Officer, effective September 17, 2026. While the section also discloses the departure of Everett W. Good as CFO, the salient event centers on the appointment of Srivastava to the principal financial officer role. The filing provides detailed background on Srivastava's qualifications and tenure, and confirms Melissa Long's appointment as principal accounting officer. This is material as it involves a change in the Company's principal financial officer position.
View raw filing on EDGAR →This Item 5.07 filing discloses the results of Network-1 Technologies' Annual Meeting of Stockholders held on September 16, 2026, including voting outcomes on three matters: (i) election of four directors (Corey M. Horowitz, Jonathan Greene, Allison Hoffman, and Niv Harizman), (ii) non-binding advisory vote on named executive officer compensation ("Say on Pay"), and (iii) ratification of Grassi & Co., CPAs, P.C. as independent auditor. The detailed vote tallies for each proposal are provided, making this a clear and unmistakable shareholder vote results disclosure.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from a special meeting held on September 18, 2026. The filing reports voting outcomes on four proposals: two reverse stock split authorizations (1-for-2 to 1-for-25 ratios), approval of the 2026 Omnibus Incentive Plan, and an adjournment proposal. The reverse stock splits are material governance and capital structure events that would affect investor assessment of the company's strategic direction and shareholder value.
View raw filing on EDGAR →Amanda Fabiano was appointed as a Class III director of Cypherpunk Technologies effective September 22, 2026. Fabiano is a veteran mining executive with significant operational experience from Nakamoto, TeraWulf, Galaxy, and Fidelity, and received RSU awards of 250,000 shares as part of her appointment.
View raw filing on EDGAR →Celldex announced positive Phase 3 trial results for barzolvolimab in chronic spontaneous urticaria (CSU), meeting primary and all key secondary endpoints. While this is technically a clinical trial result rather than financial earnings, it is disclosed via press release in Item 8.01 and represents a material milestone that would significantly affect investor assessment of the company's pipeline value and regulatory prospects. The announcement of successful Phase 3 data supporting a planned 2027 BLA submission is a transformational event for a clinical-stage biopharmaceutical company.
View raw filing on EDGAR →Contango announced completion of an updated mineral resource estimate (MRE) for the Kitsault Valley Project, showing a 93% increase in Indicated resources to 89.55 million silver-equivalent ounces based on approximately 434,000 meters of drilling. This material operational and strategic milestone reflects substantial progress toward an Initial Assessment targeted for 2027 and affects investor assessment of the project's value and development trajectory.
View raw filing on EDGAR →Knightscope disclosed approximately $27 million in estimated renewals, bookings, and client awards for May–September 2026, representing 109 contracts across seven vertical markets. This is an operational/business update disclosing material contract activity and client wins (including Fortune 500 enterprises, federal agencies, and transit systems), but it is not a formal earnings release, M&A activity, or other specifically-named event type. The disclosure is material to investors assessing the company's commercial traction and revenue pipeline, though the company explicitly disclaims that this metric is not GAAP revenue or a substitute for financial results.
View raw filing on EDGAR →This press release announces NMPA (China's National Medical Products Administration) clearance of an IND application for ADG138, a novel bispecific T-cell engager, with Phase 1 studies expected to begin in Q4 2026. This is a material regulatory milestone and clinical development advancement for a platform-driven biotech company, but it does not fit the specific event categories of earnings release, M&A activity, executive changes, or other named types. It represents a significant operational/clinical development milestone that would affect a reasonable investor's assessment of the company's pipeline progress and regulatory trajectory.
View raw filing on EDGAR →The company appointed Scott Young as Executive Vice President and Chief Operating Officer effective September 22, 2026, in a newly created C-suite role unifying business segments and reporting directly to the CEO. The filing also discloses the appointment of Dev Chakraborty as Senior Vice President and Head of Brigit as part of additions to the executive leadership team.
View raw filing on EDGAR →The Trust issued $1,250,000,000 in Class A Asset Backed Certificates and $53,572,000 in Class B Asset Backed Certificates on September 22, 2026, creating new direct financial obligations. This represents a material debt issuance of approximately $1.3 billion in asset-backed securities, which is a creation of new debt obligations and would materially affect investor assessment of the registrant's capital structure and leverage.
View raw filing on EDGAR →The 6-K announces a capital increase of TRY 8 billion in Turktell Bilişim Servisleri A.Ş., a wholly-owned subsidiary of Turkcell, with the parent company fully exercising its pre-emption rights and paying in cash. This is a material financial event involving a significant capital injection into a subsidiary, but it does not fit the specific categories of debt issuance, dilutive issuance (which typically refers to equity issuances to external parties), or other named financial event types. It is clearly a financial matter affecting the registrant's capital structure and subsidiary capitalization.
View raw filing on EDGAR →This exhibit discloses the voting results from Alibaba's 2026 Annual General Meeting held on September 22, 2026, including shareholder approval of four key resolutions: the Share Issuance Mandate (97.6% in favor), the Share Repurchase Mandate (99.8% in favor), election of three Group III directors (Maggie Wei WU, Kabir MISRA, and Weijian SHAN), and auditor appointments (PricewaterhouseCoopers entities). The detailed vote tallies, percentages, and governance context clearly match the shareholder_vote_results classification.
View raw filing on EDGAR →CenterPoint Energy Houston Electric entered into an Underwriting Agreement on September 21, 2026, to issue $700,000,000 aggregate principal amount of 5.40% General Mortgage Bonds due 2031. This is a material creation of a direct financial obligation through a public debt offering, clearly fitting the debt_issuance category. The substantial principal amount and public nature of the offering make this material to investors.
View raw filing on EDGAR →John Landry, Chief Financial Officer, is stepping down from his role effective October 2, 2026 to pursue another professional opportunity. While Loïc Moreau will serve as interim CFO, the primary disclosed action is the departure of the CFO, a named executive officer. The announcement is marked as "INSIDE INFORMATION" and is material to investors assessing leadership continuity and financial oversight during a growth phase.
View raw filing on EDGAR →Domo, Inc. completed the sale of substantially all of its assets and employees to Progress Software Corporation for approximately $221 million in cash on September 22, 2026. The company has been renamed Huckleberry.ai, Inc., will trade under the new ticker symbol 'HUCK,' and now operates as a debt-free shell with $221 million in cash and $900+ million in NOL carryforwards, representing a fundamental change of control and business transformation.
View raw filing on EDGAR →The company effected a corporate name change from Domo, Inc. to Huckleberry.ai, Inc. through a Delaware merger under Section 253, with corresponding amendments to the Certificate of Incorporation and Bylaws, and a ticker symbol change from 'DOMO' to 'HUCK' effective September 24, 2026.
View raw filing on EDGAR →The 6-K discloses non-reliance on previously issued audited consolidated financial statements for fiscal years 2024 and 2025, with the Company's intention to restate those statements. The restatement stems from SEC Staff comments that the Company lost controlling financial interest in a subsidiary (CHG) in 2024 and must deconsolidate it under ASC 810-10-15-10 and ASC 810-10-25-1. This is a classic restatement disclosure under Item 4.02 equivalent, signaling accounting trouble and requiring amended Form 20-F filings.
View raw filing on EDGAR →Quoin Pharmaceuticals announced that the FDA granted Fast Track Designation for QRX003 in Peeling Skin Syndrome, marking the first-ever Fast Track Designation for this indication and the second for the drug overall. This regulatory milestone facilitates development and expedites FDA review, materially advancing the company's clinical development program and regulatory pathway.
View raw filing on EDGAR →Randall J. Erickson, Executive Vice President, General Counsel and Corporate Secretary, is retiring effective October 13, 2026. While the disclosure includes compensatory arrangements (base salary continuation, incentive eligibility, equity vesting), the principal disclosed action is the departure of a named executive officer from his position. The Letter Agreement details are ancillary to the core event of his retirement.
View raw filing on EDGAR →The disclosure describes a conversion of Class B ordinary shares held by the Sponsor (Aldel Investors II LLC) and other Class B holders into Class A ordinary shares, effective October 5, 2026. This is a governance event involving a change in share class structure and voting rights, but does not fit the specific categories of exec_departure, exec_appointment, exec_compensation, or shareholder_vote_results. The conversion materially affects the capital structure and control dynamics of the company post-IPO, making it material to investors assessing ownership and governance.
View raw filing on EDGAR →This exhibit is a final term sheet for Brookfield Finance Inc.'s issuance of US$600,000,000 in 5.650% Senior Unsecured Notes due 2031, fully guaranteed by Brookfield Corporation. The document discloses the material terms of a new debt obligation: principal amount, coupon rate, maturity date, settlement date (September 23, 2026), and covenants. This is a material debt issuance creating a direct financial obligation for the registrant.
View raw filing on EDGAR →Brookfield Finance Inc. issued US$600,000,000 aggregate principal amount of 5.650% Notes due 2031, guaranteed by Brookfield Corporation. The underwriting agreement and prospectus supplement establish the terms and conditions for this material new debt obligation.
View raw filing on EDGAR →This exhibit announces the record date and expected completion date for a previously announced spin-off of Toro's wholly owned LPG carrier subsidiary, AI OKTO CORP. The spin-off is a material change of control / disposition event (Item 1.01 / 2.01 equivalent) that would significantly affect the registrant's capital structure and business composition. The announcement sets concrete dates (Record Date: October 1, 2026; Distribution Date: ~October 8, 2026) and distribution terms (1 AI OKTO share per 8 Toro shares), indicating material progress toward completion of a previously disclosed transaction.
View raw filing on EDGAR →PDS Biotechnology announced the publication of Phase 2 clinical trial results for PDS0101 in JAMA Oncology, demonstrating a 39.3-month median overall survival in HPV16-positive head and neck cancer patients—substantially exceeding the 17.9-month standard of care benchmark. This represents a material operational/clinical milestone for a late-stage biotech company, affecting investor assessment of the product candidate's development trajectory and commercial potential, though it does not fit the specific categories of earnings release, M&A activity, or other named event types.
View raw filing on EDGAR →The press release discloses a mechanical issue at Endeavour's Guanacevi Mine requiring temporary shutdown of the primary ball mill and replacement of the mill head and trunnion. This reduces processing capacity from ~1,100 tpd to 600 tpd during the ~3-week repair period. While the company characterizes the replacement cost as "minimal" due to on-site inventory, the operational disruption materially affects near-term production capacity and is disclosed as a material event warranting investor notification. This is an operational disruption rather than a discrete event type (not workforce reduction, not material impairment, not litigation), so operational_other is the best fit.
View raw filing on EDGAR →AutoZone issued a press release on September 22, 2026, announcing its fourth quarter and fiscal year 2026 earnings results, including net sales of $6.6 billion for Q4 and $20.3 billion for the full year, diluted EPS of $56.05 for Q4 and $152.55 for the year, and net income of $931.6 million and $2.6 billion respectively. This is a standard earnings release disclosure under Item 2.02, with detailed financial statements and operational metrics attached as Exhibit 99.1.
View raw filing on EDGAR →The FDA has lifted a clinical hold on Filana's IND application for simufilam in TSC-related epilepsy, enabling the company to proceed with a Phase 2a proof-of-concept study with patient screening expected to begin in Q1 2027. This removal of a significant development barrier is a material regulatory milestone that directly advances the company's lead drug program.
View raw filing on EDGAR →The filing discloses FDA regulatory feedback recommending that Compass conduct a survival-benefit trial before submitting a BLA for tovecimig in biliary tract cancer. This is a material operational/regulatory development affecting the company's clinical development pathway and timeline for a key product candidate. While the company disputes the FDA's recommendation and intends to further engage with the agency, the feedback materially impacts the regulatory strategy and timeline for BLA submission, making it significant to investors assessing the company's ability to advance its lead program.
View raw filing on EDGAR →The press release announces the appointment of Dr. Michael Blough as Chief Clinical Development Officer, a newly created executive position. The appointment is material because Dr. Blough will oversee critical clinical development strategy for two pivotal trials (Phase 2 psilocybin for major depressive disorder and Phase 3 MDMA for PTSD) that are central to the company's regulatory pathway and value creation. His 20+ years of experience in clinical trials and established relationships with Health Canada directly support the company's near-term clinical milestones.
View raw filing on EDGAR →Alpha Compute has executed definitive asset purchase agreements to acquire over 300 acres of surface, mineral, and gas rights in Pennsylvania, including 75 existing oil and gas wells and associated infrastructure, for a USD $5.5 million acquisition price. This constitutes a material acquisition of operating assets that would affect a reasonable investor's assessment of the company's strategic direction and capital deployment.
View raw filing on EDGAR →Wynn Resorts issued $900 million aggregate principal amount of 6.875% Senior Notes due 2035 pursuant to an indenture dated September 22, 2026. This is a clear creation of a new direct financial obligation through debt issuance, disclosed under Item 1.01 (Entry into a Material Definitive Agreement). The materiality is evident from the substantial principal amount and the company's use of proceeds to refinance existing debt.
View raw filing on EDGAR →Steven K. Burke, M.D., was appointed to the Board of Directors effective September 18, 2026, and to the Nominating and Corporate Governance Committee. Dr. Burke brings 30+ years of biopharmaceutical industry experience with specific expertise in drug development for chronic kidney disease, directly relevant to the company's SCY-770 program for ADPKD.
View raw filing on EDGAR →RTB Digital disclosed a 2027 operating forecast projecting $102 million in revenue and Adjusted EBITDA-positive operations, along with strategic updates on platform launch, customer onboarding, and the Paradium.AI partnership. This is a forward-looking operational and financial guidance disclosure that does not constitute an earnings release (which reports historical results) but rather a material strategic and operational update. The disclosure includes specific revenue projections, customer metrics, and business strategy details that would affect a reasonable investor's assessment of the company's future prospects.
View raw filing on EDGAR →XFLH Capital Corporation, a SPAC, entered into a non-binding letter of intent with Renogen Biolab Inc. on September 18, 2026 for a proposed business combination involving a health service provider with molecular capabilities. The parties have committed to negotiate definitive agreements in good faith.
View raw filing on EDGAR →YYForce announced its '2030 Vision' strategic initiative to evolve from a workforce and facility management provider into a 'Future Workforce Solutions Provider' integrating human workers, AI, and robotics. The company disclosed three core capability layers (on-demand human staffing, humanoid/service robotics via RaaS, and smart facility management) and plans to pursue this strategy through technology development, partnerships, and pilot programs, representing a material shift in business model and capital allocation priorities.
View raw filing on EDGAR →Ken Toombs was appointed to Vogenx's Board of Directors as a Class II director effective September 21, 2026, with concurrent appointments as Chair of the Audit Committee and member of the Compensation Committee and Nominating and Corporate Governance Committee. This appointment strengthens independent board oversight for the recently IPO'd clinical-stage biopharmaceutical company.
View raw filing on EDGAR →RTB Digital entered into Securities Purchase Agreements on September 16 and 22, 2026, for the unregistered sale of 494,159 shares of common stock at $11.13 per share for gross proceeds of $5,500,000 under Regulation 506(b). The shares are restricted and subject to lock-up agreements releasing in four tranches through February 2028. This is a classic private placement (PIPE-like) dilutive issuance of unregistered equity securities, disclosed under Item 3.02, with material capital-raising implications for the registrant.
View raw filing on EDGAR →